semaglutide and hydroxychloroquine 6 Things to Know About the New GLP-1 Weight Loss Pill Tirzepatide vs. Semaglutide: A Complete

Non-acylated GLP-1RAs, such as exenatide, significantly penetrate the BBB and affect brain regions like the hypothalamus, which controls appetite

Patients who experience mild gastrointestinal symptoms that resolve quickly are unlikely to develop electrolyte disturbances

For example, LY3437943 , a novel triple agonist peptide discovered by Eli Lilly that targets the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and GLP-1R (GCGR+GIPR+GLP-1R from the list above), can effectively reduce body weight and improve glycemic control in obese mice

While these medications are revolutionary for weight management and metabolic health, they can present a paradoxical relationship with sleep: recent research shows that insomnia ranks as the most common psychiatric adverse event reported with GLP-1 medications, affecting users through multiple complex mechanisms